Isolated PB B cells were labelled using the
CellTrace Violet (CTV) Cell Proliferation Kit (Life Technologies), according to manufacturer’s instructions, and cell proliferation was measured by CTV dilution. The cells were cultured in 96-well plates at 1 × 10
4 cells/well in complete medium (
Table S5) and stimulated with 2.5 µg/ml goat α-human IgA/IgG/IgM F(ab′)
2 fragments (α-Ig; Jackson ImmunoResearch Laboratories) in combination with 20 ng/ml
human recombinant IL-2 (R&D Systems) and 2.5 µg/ml TLR9 agonist,
CpG-B ODN 2006 (InvivoGen) for 5/7 d with or without antibodies recognizing CD38: α-CD38 mouse clone HB-7
(Ultra-LEAF Purified; Biolegend) and daratumumab (trade name Darzalex, human, IgG1κ, HuMax-CD38, Genmab/Janssen) both at a concentration of 1 µg/ml (de Weers et al., 2011 (
link); Laubach et al., 2014 (
link); Matas-Céspedes et al., 2017 (
link)). The proliferation was assessed as expansion index. Data were acquired by flow cytometry.
Camponeschi A., Kläsener K., Sundell T., Lundqvist C., Manna P.T., Ayoubzadeh N., Sundqvist M., Thorarinsdottir K., Gatto M., Visentini M., Önnheim K., Aranburu A., Forsman H., Ekwall O., Fogelstrand L., Gjertsson I., Reth M, & Mårtensson I.L. (2022). Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells. The Journal of Experimental Medicine, 219(9), e20220201.